Company Filing History:
1 out of 9 
1 out of 42 
Years Active: 2019
Title: Dolores Viña Castelao: Innovator in Selective MAO-B Inhibitors
Introduction
Dolores Viña Castelao is a prominent inventor based in Vigo, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of selective monoamine oxidase B (MAO-B) inhibitors. Her work focuses on addressing neurodegenerative disorders, which are increasingly prevalent in today's society.
Latest Patents
Dolores holds a patent for "Pyridazin-3(2H)-one derivatives as monoamine oxidase selective isoform B inhibitors." This invention refers to pyridazin-3(2H)-one derivatives that are selective MAO-B inhibitors. These compounds are designed for use in medicaments aimed at treating disorders resulting from MAO-B hyperactivity, such as Parkinson's disease, Alzheimer's disease, and other dementias. The derivatives feature dithiocarbamate moieties bonded to specific positions through an alkyl chain of variable length. This innovative approach offers potential therapeutic benefits for patients suffering from these debilitating conditions.
Career Highlights
Throughout her career, Dolores has been associated with esteemed institutions such as the University of Vigo and the University of Santiago de Compostela. Her academic background and research endeavors have positioned her as a key figure in the field of pharmacology and medicinal chemistry.
Collaborations
Dolores has collaborated with notable colleagues, including Ma Del Carmen Terán Moldes and Pedro Besada Pereira. These partnerships have further enriched her research and contributed to the advancement of her innovative work.
Conclusion
Dolores Viña Castelao's contributions to the development of selective MAO-B inhibitors represent a significant advancement in the treatment of neurodegenerative disorders. Her innovative research continues to pave the way for new therapeutic options, highlighting her role as a leading inventor in the field.